Related Experiment Videos
[Budd-Chiari syndrome illustrated by four case reports]
Henning Grønbaek1, Dennis Tønner Nielsen, Lone Bording Astrup
1Medicinsk afdeling V og radiologisk afdeling R, Arhus Kommunehospital, Arhus Universitetshospital, DK-8000 Arhus C. henning.gronbaek@dadlnet.dk
Ugeskrift for Laeger
|July 11, 2002
Summary
Budd-Chiari syndrome (BCS) management requires individualized treatment plans. Diverse patient cases highlight successful interventions including TIPS, venesection, anticoagulation, liver transplantation, and stenting for hepatic venous obstruction.
Area of Science:
- Hepatology
- Vascular Medicine
- Interventional Radiology
Background:
- Budd-Chiari syndrome (BCS) is characterized by hepatic venous outflow obstruction.
- Patient management is complex due to variations in obstruction location, etiology, and disease progression.
Observation:
- Four distinct BCS cases were presented.
- Case 1: Protein C deficiency, oral contraceptive use, smoking; treated with transjugular intrahepatic portosystemic shunt (TIPS).
- Case 2: Polycythemia vera; treated with venesection and anticoagulation.
- Case 3: Underwent liver transplantation.
- Case 4: Congenital vascular web; treated with stenting.
Findings:
- Successful outcomes were achieved with tailored interventions for each patient.
- Transjugular intrahepatic portosystemic shunt (TIPS) proved effective for a patient with multiple risk factors.
- Medical management (venesection, anticoagulation) and surgical options (liver transplant, stenting) were successful in other cases.
Implications:
- Individualized treatment strategies are crucial for managing Budd-Chiari syndrome.
- A range of interventional and surgical options can effectively address hepatic venous obstruction.
- Understanding patient-specific factors is key to selecting the optimal therapeutic approach for BCS.